Patents Assigned to Schering Aktiengessellschaft
  • Amide inhibitors of leukotriene A4 hydrolase
    Publication number: 20070155727
    Abstract: This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4a, R4b, R4c, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, R9 and R10 are described herein, or pharmaceutically acceptable salts, solvates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and which are therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of using and preparing the compounds of the invention are also disclosed.
    Type: Application
    Filed: December 22, 2006
    Publication date: July 5, 2007
    Applicant: Schering Aktiengessellschaft
    Inventors: Ming Chen, Emmanuel Claret, Arwed Cleve, David Davey, William Guilford, Seock-Kyu Khim, Thomas Kirkland, Monica Kochanny, Amy Liang, David Light, John Parkinson, David Vogel, Guo Wei, Bin Ye, Hong Ye
  • Growth factor receptor antibodies
    Patent number: 5942602
    Abstract: The present invention is related to single and double chain antibodies to EGF receptor. The invention also relates to toxin conjugates of such antibodies. These antibodies are useful for treating and diagnosing the status of pathological conditions such as cancer and cellular hyper proliferation.
    Type: Grant
    Filed: February 13, 1997
    Date of Patent: August 24, 1999
    Assignee: Schering Aktiengessellschaft
    Inventors: Winfried S. Wels, Mathias Schmidt, Evangelia Vakalopoulou, Douglas W Schneider